A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 248 participants.

Also called NCT01609140

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 248 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01609140
Other papers using this trial's data
  • Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study) The American journal of cardiology, 2017-05-15 DOI, PubMed 28343601 PubMed links an erratum for this paper. Erratum: PMID 29448977

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Canada, Czechia, Germany, Hungary, New Zealand, Norway, Slovakia, South Africa (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01609140. Randomized; double masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
Condition
Coronary Heart Disease
Intervention (Drug)
MPSK3169A
Intervention (Drug)
MPSK3169A
Intervention (Drug)
MPSK3169A
Intervention (Drug)
MPSK3169A
Intervention (Drug)
MPSK3169A
Intervention (Drug)
Placebo
Lead sponsor
Genentech, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01609140
Content hash
ab9d8db4566959aaaf92d1d13a0cc60459c5cb1f8ea432e858e2d5e49a398667